Monday, November 3, 2014

Can Silver Coated Dressing Prevent Surgical Site Infections in Elderly with Hip Fractures

Can Silver Coated Dressing Prevent Surgical Site Infections in Elderly with Hip Fractures – A Randomized prospective Trial
Assaf Kadar, Ety Yahav, Gilad Eisenberg, Moshe Salai
Background
Surgical site infections (SSI) after hip fracture surgery are a common complication with serious consequences both for the patient and the medical system that treats him. Silver ions are a known anti-bacterial agent; yet, the use of silver dressing in the primary prevention of surgical wound infections is controversial. We conduct a randomized controlled trial to compare silver dressing (SD) with regular dressing (RD) in the prevention of SSI in elderly patients undergoing surgery for hip fractures, and compare costs.

Methods
A matched group of 55 Patients with hip fractures undergoing surgery with dynamic hip screw, cephalomedullary nail or hemiarthroplasty were randomized to either silver dressing (n=31) or regular dressing (n=24) groups. The dressings were applied in the operating theater and the patients were followed for one week for clinical signs of infection (discharge, erythema and fever). Additionally, skin swabs were taken from the wound surface on day 5-7 post operative for bacterial skin colonization. The use of SD was according to the manufacturer instruction, i.e. they were not removed for 5-7 days and kept moist.

Results
There were no significant differences between the SD and RD groups with regard to age, sex or co-morbidities. 2 of 31 (6.4%) patients in the silver dressing group had signs of infection compared to 2 of 24 (8.3%) in the regular dressing group (p=1). Skin colonization by bacteria at day 5-7 post-operative was higher in the silver dressing group with 12 of 19 (63%) patients with positive skin swab, as compared to 50% in the regular dressing group (p=0.67). additional costs for the use of SD were ~5.5 US$ per patient.     
  
Conclusion
The use of silver dressing is associated with higher costs; yet, it was not superior to regular dressing in preventing surgical site infections in patients undergoing hemiarthroplasty or fixation of hip fractures. Additionally, silver dressing was not effective in reducing bacterial skin colonization following the aforementioned injury and operation. 


Table I: General patients demographic, co-morbidities and the chance to develop an infection according to type of dressing used (Silver dressing or regular dressing)

Whole Cohort (N=55)
Silver Dressing (N=31)
Regular Dressing (N=24)
p-value
General Patients' Demographics
Male/Female
18/37
11/20
7/17
0.77ǂ
Age (SD)
79.6 (12.37)
80.2 (12.54)
78.83 (12.36)
0.66*
Type of surgery (ORIF/Hemiarthroplasty)
38/17
23/8
15/9
0.39ǂ
Co-morbidities
Hypertension (%)
29 (52%)
15 (48%)
14 (58%)
0.58ǂ
Diabetes (%)
9 (16%)
7 (22%)
2 (8.3%)
0.27ǂ
Heart Disease (%)
23 (41%)
9 (29%)
14 (58%)
0.052ǂ
CVA (%)
8 (14%)
2 (6%)
6 (25%)
0.06ǂ
COPD (%)
6 (10%)
4 (13%)
2 (8.3%)
0.68ǂ
Tracers of post operative infection
Positive Skin culture 5-7 days post operative (%)
16/27 (59%)
12 (63%)
4 (50%)
0.67ǂ
Signs of infection (%)
4/55 (7.2%)
2 (6.4%)
2 (8.3%)
1ǂ
ǂ Fisher exact test
* Student unpaired t-test

ORIF, open reduction and internal fixation (Dynamic hip screw and cephalomedullary nail); CVA, Cerebrovascular accident; COPD, Chronic obstructive pulmonary disease